Delisting risk
Co-Diagnostics (CODX)
Develops portable PCR instruments, test cups, and molecular assays.
$1.11
Pre-market−0.04 (−3.90%)
At close$1.16(−2.94%)
Something off on this page? Send us feedback.
Next report
Nov 16, 2026
in 74 days
EPS estimate
−$1.25
Revenue estimate
$169.0K
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.36−$0.24−$0.23−$4.80−$16.35−$4.06−$1.46Pending
Estimate−$0.34−$0.33−$0.25−$5.71−$3.60−$3.75−$3.00−$1.25
Surprise−5.9%+27.3%+8.0%+15.9%−354.2%−8.3%+51.3%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$149.3K$50.3K$162.9K$145.4K$262.5K$146.0K$166.1KPending
Estimate$375.0K$187.5K$300.0K$126.0K$125.9K$127.1K$132.6K$169.0K
Surprise−60.2%−73.2%−45.7%+15.4%+108.5%+14.9%+25.3%—
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$1.25 | — | — |
| Aug 2026 | −$3.00 | −$1.46 | +51.3% |
| May 2026 | −$3.75 | −$4.06 | −8.3% |
| Mar 2026 | −$3.60 | −$16.35 | −354.2% |
| Nov 2025 | −$5.71 | −$4.80 | +15.9% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| Mar 2017 | |||
| Dec 2016 | |||
| Sep 2016 | |||
| Jun 2016 | |||
| Mar 2016 | |||
| Dec 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Nov 16, 2026 | −$1.25 | — | — | $169.0K | — | — | — |
| Aug 13, 2026 | −$3.00 | −$1.46 | +51.3% | $132.6K | $166.1K | +25.3% | −6.0% |
| May 14, 2026 | −$3.75 | −$4.06 | −8.3% | $127.1K | $146.0K | +14.9% | −20.9% |
| Mar 31, 2026 | −$3.60 | −$16.35 | −354.2% | $125.9K | $262.5K | +108.5% | −12.9% |
| Nov 13, 2025 | −$5.71 | −$4.80 | +15.9% | $126.0K | $145.4K | +15.4% | −11.0% |
The latest year is open to everyone — the 39 quarters behind it read with an account. Sign in | |||||||
| Aug 14, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 27, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 16, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 11, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 16, 2020 | |||||||
| Aug 13, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 31, 2020 | |||||||
| Nov 13, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Apr 2, 2019 | |||||||
| Nov 14, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 28, 2018 | |||||||
| Nov 14, 2017 | |||||||
| Aug 25, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Dec 31, 2016 | |||||||
| Sep 30, 2016 | |||||||
| Jun 30, 2016 | |||||||
| Mar 31, 2016 | |||||||
| Dec 31, 2015 | |||||||